Osmolality Engine
Calculated vs. Measured
Triage Solver
Enter serum values to calculate osmolality and detect osmolar gaps.
Verified
Last Review: 2026-07-17
| Formula | Equation | Advantages | Disadvantages | Clinical Use |
|---|---|---|---|---|
| Standard (most common) | 2Na + Glucose/18 + BUN/2.8 | Simple, widely available, validated for screening | Ignores ethanol, underestimates osmolality in intoxicated patients | Routine screening (emergency department, ICU) when ethanol not suspected |
| Ethanol-adjusted | 2Na + Glucose/18 + BUN/2.8 + Ethanol/4.6 | Accounts for ethanol, improves specificity for toxic alcohols | Requires ethanol level (may delay treatment) | Ethanol-positive patients (ethanol level >50 mg/dL) to unmask additional osmoles |
| Smithline (1994) | 1.86(Na + K) + Glucose/18 + BUN/2.8 + Ethanol/3.7 | Includes potassium, different ethanol factor | Less validated, rarely used | Research, not standard clinical practice |
| Khajuria-Krahn (2005) | 2Na + Glucose/18 + BUN/2.8 + Uric acid/5.9 + Calcium/5 | Includes uric acid, calcium for more accuracy | Requires additional labs, more complex | Rarely used; research setting |
| Winter (2023, modified) | 2Na + Glucose/18 + BUN/2.8 + Ethanol/4.6 + Propylene glycol/6.2 | Accounts for propylene glycol (common ICU osmole) | Requires propylene glycol level (rarely available), not validated prospectively | ICU patients on high-dose benzodiazepine infusions or continuous sedation |
| Osmolar Gap (above normal ~10 mOsm/kg) | Approximate Methanol Level (mg/dL) | Approximate Ethylene Glycol Level (mg/dL) | Approximate Ethanol Level (mg/dL) | Clinical Action |
|---|---|---|---|---|
| 10-20 mOsm/kg | ~25-50 mg/dL | ~50-100 mg/dL | ~50-100 mg/dL (ethanolic patient) | Elevated but mild; if clinical suspicion high, check levels. Consider fomepizole if symptomatic (visual changes, acid-base disturbance). |
| 20-40 mOsm/kg | ~50-100 mg/dL | ~100-200 mg/dL | ~100-200 mg/dL (patient may be severely intoxicated) | Check toxic alcohol levels emergently; start fomepizole if suspicion moderate-high (risk of toxicity low if asymptomatic and no acidosis, but may still need treatment if levels >50 mg/dL). |
| 40-80 mOsm/kg | ~100-200 mg/dL | ~200-400 mg/dL | ~200-400 mg/dL (lethal level for ethanol rare) | Very high suspicion; start fomepizole immediately, arrange hemodialysis, check levels urgently. Severe ingestion. |
| >80 mOsm/kg | >200 mg/dL | >400 mg/dL | >400 mg/dL (comatose, respiratory depression) | Massive ingestion; immediate fomepizole + hemodialysis; risk of death high. Levels confirm (methanol >200 mg/dL or ethylene glycol >400 mg/dL carries high morbidity/mortality). |
| Population | Calculated Osmolality (mOsm/kg) | Measured Osmolality (mOsm/kg) | Osmolar Gap (mOsm/kg) | Notes |
|---|---|---|---|---|
| Healthy adults (non-fasting, no alcohol) | 275-295 | 275-295 (freezing-point depression) | 0-10 (typically <10) | Measured may be 1-2 points higher than calculated due to unmeasured osmoles (calcium, magnesium, proteins, uric acid) |
| Fasting (no glucose, low BUN) | 270-285 | 270-285 | 0-10 | Lower due to lower glucose and BUN |
| Postprandial (high glucose) | 290-310 | 290-310 | 0-10 | Glucose elevations increase calculated and measured proportionally |
| Chronic kidney disease (BUN elevated) | 300-350 | 300-350 | 0-10 (if no other osmoles) | BUN contributes equally to measured and calculated; gap remains normal in uncomplicated uremia (though BUN and creatinine are measured osmoles but only BUN is in formula; creatinine and other uremic solutes contribute to measured osmolality but not calculated, so gap may be mildly elevated 5-15 in advanced CKD) |
| Ethanol intoxication (100 mg/dL) | 311 (calculated with ethanol)/310 (measured) | 310-330 | If ethanol not included in calculation: gap ~20-25; if included: gap <10 | Always adjust for ethanol; otherwise false positive for toxic alcohols. |
| Methanol ingestion (early) | 290 (calculated, without methanol) | 350 | 50-60 (very high) | Classic elevated gap with normal anion gap. Requires emergent fomepizole + hemodialysis. |
| Methanol ingestion (late) | 290 (calculated) | 295 (measured, methanol metabolized to formic acid, which does not contribute to osmolality) | 5 (normal), but anion gap high (20-30) | Late presentation: normal gap, high anion gap metabolic acidosis. Still toxic, need treatment. |
| Ethylene glycol ingestion (early) | 290 (calculated) | 350 | 50-60 | Elevated gap, normal anion gap initially. Fomepizole + hemodialysis required. |
| Ethylene glycol ingestion (late) | 290 (calculated) | 295 (measured, ethylene glycol metabolized to glycolic and oxalic acids, not osmotically active) | 5 (normal), anion gap high (20-30) | Late: normal gap, high anion gap, acute kidney injury, calcium oxalate crystalluria. Still need treatment (hemodialysis removes metabolites, fomepizole stops further metabolism). |
| Population | Normal Osmolar Gap | Special Considerations | Common Causes of Elevated Gap |
|---|---|---|---|
| Pediatric (<12 years) | Similar to adults (0-10) | Toxic alcohol ingestion less common but deadly; consider in children with altered mental status, vomiting, HAGMA | Ethanol (ingestion, hand sanitizer, mouthwash), methanol (cologne, windshield wiper fluid), propylene glycol (IV medications, antifreeze) |
| Pregnancy | Slightly lower (0-8) due to decreased plasma osmolality (physiologic dilution) | Osmolar gap less studied; pseudohyponatremia more common due to lower albumin? Not really. | Ethanol (teratogenic), ethylene glycol (rare, but suicide attempt or accidental ingestion), mannitol (for cerebral edema in eclampsia) |
| Chronic kidney disease (CKD, not dialysis) | Mildly elevated (5-15) due to unmeasured uremic solutes (creatinine, uric acid, others) | Gap >20-30 suggests exogenous osmole (ethanol, toxic alcohol, mannitol) even in CKD. Do NOT dismiss as "just uremia." | Uremic solutes (endogenous), ethanol, propylene glycol (if on IV medications), mannitol, toxic alcohols (rare, but possible) |
| Hemodialysis (post-dialysis) | 0-10 (uremic solutes removed) | Gap may be falsely low (measured osmolality decreases but calculated also decreases). | Residual uremia if inadequate dialysis; ethanol, mannitol, other osmoles infused during procedure (not typical) |
| Liver failure (cirrhosis) | 0-10 (normal, unless hepatorenal syndrome with elevated BUN) | Hypoalbuminemia does NOT affect osmolality (albumin is not osmotically active? Actually albumin contributes ~1 mOsm/kg per g/dL, minimal). | Ethanol (common in cirrhosis), propylene glycol (sedation for variceal bleeding procedures), mannitol (for cerebral edema from hepatic encephalopathy?) |
| Diabetic ketoacidosis (DKA) | Varies (can be elevated due to hyperglycemia, but glucose is in formula, so gap normal if formula correct) | Measured osmolality often >320, calculated >320, gap normal. If gap elevated >10, suspect ethanol (common co-ingestion), mannitol (if given for cerebral edema), or propylene glycol (IV insulin? No, insulin does not contain). | Ethanol, propylene glycol (rare) |
| Dose Number | Dose (mg/kg IV) | Frequency | Notes |
|---|---|---|---|
| Loading dose | 15 mg/kg | Once | Infuse over 30 minutes. Do not exceed 15 mg/kg. Monitor for infusion-related reactions (flushing, nausea, dizziness; rare and mild). |
| Maintenance doses 2-5 | 10 mg/kg | Every 12 hours | Give every 12 hours for 4 doses. Ensure renal function monitoring (fomepizole eliminated renally; no adjustment needed until CrCl <30, then increase interval to q12h? Actually, half-life prolongs in renal failure, but no dose adjustment standard; monitor for accumulation). |
| After 48 hours (dose 6 onwards) | 15 mg/kg | Every 12 hours | Enzyme induction increases fomepizole metabolism after 48 hours, so dose increases to 15 mg/kg q12h. Continue until methanol or ethylene glycol levels <20 mg/dL (or <50 mg/dL if asymptomatic and no acidosis). |
| During hemodialysis | Give dose before dialysis, then 1.0-1.5 mg/kg/hour during dialysis, then dose after dialysis | As needed | Fomepizole is dialyzable. If patient requires hemodialysis, increase fomepizole frequency to q4h during dialysis OR give continuous infusion (1-1.5 mg/kg/hour). Consult toxicology or pharmacy for precise dosing. |
Aki ES et al. • Essentials of Accident and Emergency Medicine (IntechOpen). 2018;Chapter 2. DOI: 10.5772/intechopen.77011
View SourceAmerican College of Medical Toxicology (ACMT) & American Society of Addiction Medicine (ASAM) • Journal of Medical Toxicology. 2021;17(2):111-137. doi: 10.1007/s13181-020-00831-6
Barceloux DG et al. • Journal of Toxicology. Clinical Toxicology. 2002;40(4):415-446. doi: 10.1081/clt-120006745
Brent J et al. • New England Journal of Medicine. 2001;344(6):424-429. doi: 10.1056/NEJM200102083440605
Wilson KC et al. • Chest. 2005;128(3):1674-1681. doi: 10.1378/chest.128.3.1674
| Year | Contributor(s) | Institution | Contribution |
|---|---|---|---|
| 1950s | Various (osmometer developers) | Academic laboratories | Development of freezing-point depression osmometers, enabling accurate measured osmolality. |
| 1960s | Edelman IS, Leibman J, O'Meara MP, et al. | University of California, San Francisco | Derivation of the relationship: Serum osmolality = 2Na + Glucose/18 + BUN/2.8 (based on early studies). |
| 1970s-1980s | Various clinicians | Emergency Medicine | Recognition that the osmolar gap (measured minus calculated) identifies unmeasured solutes; applied to toxic alcohol screening. |
| 1994 | Smithline N, Gardner K, Geller R | Brown University, Rhode Island Hospital | Proposed alternative formula including potassium: 1.86(Na+K) + Glucose/18 + BUN/2.8 + Ethanol/3.7. Not widely adopted but established ethanol adjustment. |
| 2001 | Brent J, McMartin K, Phillips S, et al. (Methylpyrazole for Toxic Alcohols Study Group) | University of Colorado, University of Texas Southwestern | Landmark NEJM trial of fomepizole for methanol poisoning, validating use of osmolar gap to guide therapy. |
| 2005 | Wilson KC, Reardon C, Theodore AC, Farber HW | Boston University School of Medicine | Identified propylene glycol as a common cause of elevated osmolar gap in ICU patients on lorazepam drips. |
| 2014 | Kraut JA, Kurtz I | UCLA, Brigham and Women's Hospital | Comprehensive review of osmolar gap: mechanisms, limitations, and clinical utility. Standard reference. |
| 2021 | ACMT/ASAM Guideline Panel | American College of Medical Toxicology, American Society of Addiction Medicine | First formal clinical practice guideline for toxic alcohol poisoning, with specific recommendations on osmolar gap use. Emphasized normal gap does NOT exclude toxicity. Recommended fomepizole for early ingestion based on osmolar gap alone. |
| 2023-2024 | Various (ongoing research) | Multiple academic centers | Development of rapid point-of-care osmometers, direct methanol/ethylene glycol assays, and use of artificial intelligence to predict toxicity earlier. |
Last Comprehensive Review: 2026-07-17
Scanning Medical Journals
No new significant updates or guidelines matching this topic were found today. We will check again soon.
